Sandbox Reserved 1716

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 7: Line 7:
[[Image:VKORimage3.png|400px|right|thumb|Figure 1. Closed Conformation of VKOR due to Warfarin Binding]]
[[Image:VKORimage3.png|400px|right|thumb|Figure 1. Closed Conformation of VKOR due to Warfarin Binding]]
===Vitamin K Cycle===
===Vitamin K Cycle===
 +
Vitamin K Epoxide Reductase has a large role in the Vitamin K Cycle. The vitamin K Cycle, and the VKOR enzyme are common drug targets for thromboembolic diseases. This is because, as pictured, the vitamin K cycle is the process in which blood coagulant factors II, VII, IX, and X are activated. This promotes blood clotting, which can be dangerous and cause thromboembolic diseases such as stroke, deep vein thrombosis, and/or pulmonary embolism.
===Location of Enzyme ===
===Location of Enzyme ===
== Structure ==
== Structure ==

Revision as of 15:13, 24 March 2022

Vitamin K Epoxide Reductase

Structure of Closed Vitamin K Epoxide Reductase (PDB entry 6wv3)

Drag the structure with the mouse to rotate

References

  1. Ransey E, Paredes E, Dey SK, Das SR, Heroux A, Macbeth MR. Crystal structure of the Entamoeba histolytica RNA lariat debranching enzyme EhDbr1 reveals a catalytic Zn(2+) /Mn(2+) heterobinucleation. FEBS Lett. 2017 Jul;591(13):2003-2010. doi: 10.1002/1873-3468.12677. Epub 2017, Jun 14. PMID:28504306 doi:http://dx.doi.org/10.1002/1873-3468.12677
Personal tools